Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sarah Lawton"'
Autor:
Pippa Corrie, Hanhua Liu, Sarah Lawton, Rebecca Smittenaar, Bukky Juwa, David Chao, Ruth E Board
Publikováno v:
International Journal of Cancer
Immune checkpoint inhibitors (CPIs) have radically changed outcomes for patients diagnosed with metastatic melanoma globally in the last 10 years, based on evidence of overall survival (OS) benefits generated from international randomised controlled
Autor:
Tom Roques, Louise Miller, Sarah Lawton, K. Spencer, Philippa Lewis, David Sebag-Montefiore, Mererid Evans, Catherine Roe, Rebecca Girdler, Christopher M. Jones, Michael Sharpe, Rebecca Smittenaar, Eva Morris
Publikováno v:
The Lancet. Oncology
The Lancet Oncology
The Lancet Oncology
BACKGROUND: The indirect impact of the COVID-19 pandemic on cancer outcomes is of increasing concern. However, the extent to which key treatment modalities have been affected is unclear. We aimed to assess the impact of the pandemic on radiotherapy a
Autor:
T. Henrik-Brodtkorb, Rebecca Smittenaar, Alice Turnbull, A. Sowdani, B. Rothwell, S. Popat, Martine Bomb, C. Ling, C. Kiff, N. Tanna, Sarah Lawton, S. Hartridge-Lambert
Publikováno v:
Journal of Thoracic Oncology. 16:S637-S638
Autor:
Esther Bastiaannet, C.J.H. van de Velde, Harm J. T. Rutten, Lene Hjerrild Iversen, Olaf M. Dekkers, H. Ortiz, Anna Martling, G.J. Liefers, A.J. Breugom, Tim J. Evans, Katie M O'Brien, Robert Johansson, Valery E.P.P. Lemmens, R. Janciauskiene, E. Van Eycken, Petra G. Boelens, Sarah Lawton
Publikováno v:
European Journal of Surgical Oncology, 44(9), 1338-1343. W.B. Saunders
EJSO-European Journal of Surgical Oncology, 44(9), 1338-1343
Breugom, A J, Bastiaannet, E, Boelens, P G, Van Eycken, E, Iversen, L H, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, K M, Ortiz, H, Janciauskiene, R, Dekkers, O M, Rutten, H J T, Liefers, G J, Lemmens, V E P P & van de Velde, C J H 2018, ' Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer-A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania ', European Journal of Surgical Oncology, vol. 44, no. 9, pp. 1338-1343 . https://doi.org/10.1016/j.ejso.2018.05.025
European Journal of Surgical Oncology, 44(9), 1338-1343. ELSEVIER SCI LTD
EJSO-European Journal of Surgical Oncology, 44(9), 1338-1343
Breugom, A J, Bastiaannet, E, Boelens, P G, Van Eycken, E, Iversen, L H, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, K M, Ortiz, H, Janciauskiene, R, Dekkers, O M, Rutten, H J T, Liefers, G J, Lemmens, V E P P & van de Velde, C J H 2018, ' Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer-A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania ', European Journal of Surgical Oncology, vol. 44, no. 9, pp. 1338-1343 . https://doi.org/10.1016/j.ejso.2018.05.025
European Journal of Surgical Oncology, 44(9), 1338-1343. ELSEVIER SCI LTD
Introduction: The aim of this EURECCA international comparison is to compare oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer between European countries.Material and methods: Population-based national co
Autor:
E. Van Eycken, Sarah Lawton, Lene Hjerrild Iversen, T. Evans, R. Janciauskiene, Petra G. Boelens, Esther Bastiaannet, Robert Johansson, Andrés Cervantes, Valery E.P.P. Lemmens, G.J. Liefers, Anna Martling, A.J. Breugom, Katie M O'Brien, C.J.H. van de Velde
Publikováno v:
Breugom, A J, Bastiaannet, E, Boelens, P G, Iversen, L H, Martling, A, Johansson, R, Evans, T, Lawton, S, O'Brien, K M, Van Eycken, E, Janciauskiene, R, Liefers, G J, Cervantes, A, Lemmens, V E P P & van de Velde, C J H 2016, ' Adjuvant chemotherapy and relative survival of patients with stage II colon cancer-A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania ', European journal of cancer (Oxford, England : 1990), vol. 63, pp. 110-7 . https://doi.org/10.1016/j.ejca.2016.04.017
European Journal of Cancer, 63, 110-117. Elsevier Ltd.
European Journal of Cancer, 63, 110-117
European Journal of Cancer, 63, 110-117. Elsevier Ltd.
European Journal of Cancer, 63, 110-117
BACKGROUND: The aim of the present EURECCA international comparison is to compare adjuvant chemotherapy and relative survival of patients with stage II colon cancer between European countries.METHODS: Population-based national cohort data (2004-2009)
Autor:
David Sebag-Montefiore, Ariadni Aravani, Eva Morris, J. D. Thomas, Sarah Lawton, Paul J. Finan, Amy Downing
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 27(12)
Between 1987 and 1994, three randomised phase III trials showed that chemoradiotherapy with mitomycin C and 5-fluorouracil was superior to radiotherapy alone (ACT1, European Organization for Research and Treatment of Cancer) or radiotherapy with 5-fl
Autor:
Amy Downing, Adam Glaser, Michael J Richards, David Sebag-Montefiore, Eva Morris, Charlotte Wood, Paul Kind, Paul J. Finan, Richard Wagland, Penny Wright, Sally W. Vernon, Richard G. Feltbower, Sarah Lawton, James D. Thomas, Jessica Corner
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(6)
Purpose This population-level study was conducted to define the health-related quality of life (HRQL) of individuals living with and beyond colorectal cancer (CRC) and to identify factors associated with poor health outcomes. Patients and Methods All